| Product Code: ETC7676786 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Italy Lumasiran Market Overview |
3.1 Italy Country Macro Economic Indicators |
3.2 Italy Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Italy Lumasiran Market - Industry Life Cycle |
3.4 Italy Lumasiran Market - Porter's Five Forces |
3.5 Italy Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Italy Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Italy Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Italy Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Italy Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Italy Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Italy Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare diseases such as Primary Hyperoxaluria Type 1 (PH1) in Italy |
4.2.2 Growing awareness and adoption of gene-silencing therapies in the Italian healthcare system |
4.2.3 Favorable government regulations and policies supporting the development and commercialization of orphan drugs in Italy |
4.3 Market Restraints |
4.3.1 High cost of lumasiran treatment may limit access for patients and reimbursement challenges |
4.3.2 Limited healthcare infrastructure and expertise for the diagnosis and management of rare diseases in Italy |
4.3.3 Competition from other emerging gene-silencing therapies in the Italian market |
5 Italy Lumasiran Market Trends |
6 Italy Lumasiran Market, By Types |
6.1 Italy Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Italy Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Italy Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Italy Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Italy Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Italy Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Italy Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Italy Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Italy Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Italy Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Italy Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Italy Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Italy Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Italy Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Italy Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Italy Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Italy Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Italy Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Italy Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Italy Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Italy Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Italy Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Italy Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Italy Lumasiran Market Import-Export Trade Statistics |
7.1 Italy Lumasiran Market Export to Major Countries |
7.2 Italy Lumasiran Market Imports from Major Countries |
8 Italy Lumasiran Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for lumasiran in Italy |
8.2 Number of healthcare providers trained in the administration of lumasiran therapy |
8.3 Rate of successful reimbursement applications for lumasiran treatment from Italian healthcare payers |
9 Italy Lumasiran Market - Opportunity Assessment |
9.1 Italy Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Italy Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Italy Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Italy Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Italy Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Italy Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Italy Lumasiran Market - Competitive Landscape |
10.1 Italy Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Italy Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here